Why the study?
Does ZVAD-fmk reduce myocardial infarct size and apoptosis in Sprague-Dawley rats subjected to ischemia/reperfusion injury?
Does ZVAD-fmk reduce myocardial infarct size and apoptosis in Sprague-Dawley rats subjected to ischemia/reperfusion injury?
The caspase inhibitor ZVAD-fmk effectively reduces myocardial reperfusion injury and cardiomyocyte apoptosis in a rat model.
No takes yet. Share an insight, caveat, or question.
Reduces infarct size and apoptosis in rat I/R injury; hypothesis-generating for caspase inhibition in human reperfusion.
Yaoita et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: